Post Medical Surveillance necessary to reshuffle.

Published: 2005-09-09 07:00:00

Updated: 2005-09-09 07:00:00

In the discussion meeting for the drug safety system, its present status and future improvement jointly sponsored by Hyun Aeja Clinics and Keonyak, Mr. Kim Seong-eun of LG Life Science said that the current post market surveillance (PMS) system raised many problems and should be reshuffled at qui...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK